Skip to main content

View preliminary programme (PDF) 

Scientific Programme

THURSDAY 16 May 2019

Cardiovascular Pharmacotherapy in Older People

An educational project by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy

08:30 – 09:00       Registration

09:00 – 09:10       Welcome, introduction and course objectives, Thomas Andersen Schmidt, Keld Kjeldsen, Heinz Drexel

09:10 – 10:00       Session 1: General Aspects

  

09:10 - 09:25

Demographical developments, and feasibility of treating older patients in a short stay unit, the “Elder” trial
Thomas Andersen Schmidt

09:25 - 09:30

Discussion

09:30 - 09:55

Drug metabolism and excretion in older people

Juan Tamargo

09:55 - 10:00

Discussion

10:00 – 10:30       Session 2: Diuretics

  

10:00 - 10:25

Diuretics and salts in older patients
Keld Kjeldsen

10:25 - 10:30

Discussion

10:30 – 10:45       Coffee break, Networking, Poster Viewing

10:45 – 11:15       Session 3: Antihypertensives

  

10:45 - 11:10

Benefit versus drawback of blood pressure treatment in older patients

Claudio Borghi

11:10 - 11:15

Discussion

 

11:15 – 12:00       Session 4: NOACs

  

11:15 - 11:25

Benefit versus drawback of NOAC treatment in older patients

Alexander Niessner

11:25 - 11:30

Discussion

11:30 - 12:00

Workshop including case stories

Heinz Drexel & Keld Kjeldsen & Thomas Andersen Schmidt

12:00 – 13:00       Lunch break, Networking

13:00 – 13:30       Session 5: Antiarrhythmics

  

13:00 - 13:25

Atrial fibrillation and case story

Kurt Huber

13:25 - 13:30

Discussion

13:30 – 14:00       Session 6: Lipid lowering drugs

  

13:30 - 13:55

Lipidology and case story

Heinz Drexel

13:55 - 14:00

Discussion

 

14:00 – 14:30       Coffee break, Networking, Poster Viewing

14:30 – 15:00       Session 7: Glucose lowering drugs

  

14:30 - 14:55

Tight glycemic control, pro et con

Heinz Drexel (pro); Thomas Andersen Schmidt (con)

14:55 - 15:00

Discussion

15:00 – 16:30       Session 8: Polypharmacy

  

15:00 - 15:15

Polypharmacy in older people

Juan Tamargo

15:15 - 15:20

Discussion

15:20 - 15:55

Workshop including case stories

Heinz Drexel & Keld Kjeldsen & Thomas Andersen Schmidt

15:55 - 16:00

Discussion

16:00                     Coffee, Networking

Friday 17 May 2019

08:30 – 09:30       Session 1: Cardiovascular Pharmacotherapy in the young

 

Chairpersons: Gianluigi Savarese & Alexander Niessner

08:30 - 08:45

Anticoagulation below 65 years of age
Patrick Sulzgruber

08:45 - 08:50

Discussion

08:50 - 09:05

Diabetes in the young and cardiovascular disease - type 1, MODY
Peter Fasching

09:05 - 09:10

Discussion

09:10 - 09:25

Inborn errors of lipid metabolism and cardiovascular disease
Harald Sourij

09:25 - 09:30

Discussion

09:30 – 10:30       Session 2: A metabolic morning – cardiovascular pharmacotherapy in middle-aged women and men

 

Chairpersons: Basil Lewis & Christian Torp-Pedersen

09:30 - 09:45

Is there a gender bias in cardiovascular pharmacotherapy?
Alexandra Kautzky-Willer

09:45 - 09:50

Discussion

09:50 - 10:05

Lipid therapy at the end of an Odyssey
Heinz Drexel

10:05 - 10:10

Discussion

10:10 - 10:25

Which drug to choose for the cardiovascular patient with diabetes?
Alexander Niessner

10:25 - 10:30

Discussion

10:30 – 11:30 :     Coffee break, Networking, Poster Viewing

11:00 – 11:15       Opening Ceremony, Heinz Drexel

11:15 – 12:15       Session 3: Cardiovascular Pharmacotherapy at old age

 

Chairpersons: Thomas Andersen Schmidt & Heinz Drexel

11:15 - 11:30

The heterogeneity of antihypertensive drugs: does it clinically matter? (intra- and interclass comparisons)
Claudi Borghi

11:30 - 11:35

Discussion

11:35 - 11:50

Anticoagulation – prevention and treatment of bleeding
Sven Wassmann

11:50 - 11:55

Discussion

11:55 - 12:10

Cardiovascular therapy of diabetes at old age (“Diabetes therapy at old age”)
Thomas Andersen Schmidt

12:10 - 12:15

Discussion

12:15 – 13:15       Lunch break, Networking, Poster Viewing

12:30 – 13:15       Lunchtime session: How to optimise the cardiovascular risk of your patient

 

Chairpersons: Claudio Ceconi & Thomas Wascher

12:30 - 12:52

Risk factor and lifestyle modifications to reduce cardiovascular risk
Guiseppe Rosano

12:53 - 13:15

Non-attainment of lipid goals
Andreas Festa

13:30 – 14:30       Session 4: Late-breaking news

 

Chairpersons: Sven Wassmann & Alexander Niessner

13:30 - 13:45

Treatment of cardiac amyloidosis
Julia Mascherbauer

13:45 - 13:50

Discussion

13:50 - 14:05

Reduce it
Thomas Wascher

14:05 - 14:10

Discussion

14:10 - 14:25

Augustus
tba

14:25 - 14:30

Discussion

14:30 – 15:30       Session 5: Viennese cardiologists

 

Chairpersons: Georg Delle-Karth & Andrea Podczeck-Schweighofer

14:30 - 14:45

Duration of DAPT - new ESC recommendations
Georg Delle-Karth

14:45 - 14:50

Discussion

14:50 - 15:05

Thrombus detection, consequences and anticoagulation after TAVI
Christian Hengstenberg

15:05-15:10

Discussion

15:10 - 15:25

Antithrombotic Strategy after PCI and Atrial Fibrillation -  the European vs the US approach
Kurt Huber

15:25-15:30

Discussion

15:30 – 16:30       Coffee break, Networking, Poster Viewing

16:00 – 17:00       Session 6: Thrombosis and inflammation

 

Chairpersons: Stefan Agewall & Augusto Gallino

 

Joint session with ISCP

16:00 - 16:15

Vascular pharmacotherapy beyond cardiovascular - Antithrombotics
Augusto Gallino

16:15 - 16:20

Discussion

16:20 - 16:35

Antiinflammatory therapy after CANTOs - A word of caution
Juan Carlos Kaski

16:35 - 16:40

Discussion

16:40 - 16:55

Inflammatory disease and atherosclerosis
Anne Grete Semb

16:55 - 17:00

Discussion

17:00 – 17:45       Session 7: Keynote Lecture

 

Chairperson: Stefan Agewall

17:00 - 17:45

SGLT 2
Anna Norhammar

18:00 – 18:30       General Assembly of the ESC Working Group on Cardiovascular Pharmacotherapy

Saturday 18 May

08:00 – 08:30       Morning symposium: Diagnostic to assist cardiovascular pharmacotherapy

 

Chairperson: Christoph Saely and Sven Wassmann

08 :00 – 08 :15

Lipids and glucose

Heinz Drexel

08 :15 – 08 :30

Atherosclerosis and atrial fibrillation

Alexander Niessner

08:30 – 09:30       Session 8: Special aspects of age: hypertension and regulatory issues

 

Chairpersons: Anne Grete Semb and Keld Kjeldsen

08:30 - 08:45

Electrolytes
Keld Kjeldsen

08:45 - 08:50

Discussion

08:50 - 09:05

Regulatory aspects
Giuseppe Rosano

09:05 - 09:10

Discussion

09:10 - 09:25

Drug metabolism and excretion in older people
Juan Tamargo

09:25 - 09:30

Discussion

09:30 – 10:30       Session 9: Ageing, co-morbidities and heart failure: a complicated relationship

 

Chairpersons: Giuseppe Rosano & Gianluigi Savarese & Eva Jankowska

 

Joint session with CPPT - HFA - HOT

09:30 - 09:45

Role of comorbidities in HFpEF vs. HFrEF
Mitja Lainscak

09:45 - 09:50

Discussion

09:50 - 10:05

Upcoming pharmacological treatments in HF
Davide Stolfo (CPPT)

10:05 - 10:10

Discussion

10:10 - 10:25

Polypharmacotherapy in elderly HF patients
Giuseppe Vergaro (HoT)

10:25 - 10:30

Discussion

10:30 – 11:00       Coffee break, Networking, Poster Viewing

11:00 – 12:00       Session 10: Myocardial infarction without coronary occlusion

 

Chairperson: Stefan Agewall

11:00 - 11:15

Definition of MINOCA

Stefan Agewall

11:15 - 11:35

Epicardial and Microvascular coronary dysfunction in MINOCA

Juan Carlos Kaski

11:35 - 11:50

Case MINOCA

Domenico D´Amario

11:50 - 12:00

Discussion

12:00 – 13:00       Session 11: Keynote Lecture & Closing Ceremony

 

Chairpersons: Juan Carlos Kaski & Claudio Borghi

12:00 - 12:30

Importance of blood pressure measurements – clinic blood pressure or ambulatory blood pressure
Christian Torp-Pedersen

12:30 - 12:40

Discussion

12:40 - 13:00

Closing & award ceremony
Heinz Drexel & Alexander Niessner